Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells

International Journal of Cancer

Volumn 82, Issue 3, 1999, Pages 435-441

  Fulda, Simone ^a   Jeremias, Irmela ^b   Steiner, Hans H ^c   Pietsch, Torsten ^d   Debatin, Klaus Michael ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETULIC ACID; BONGKREKIC ACID; CASPASE; CASPASE 3; CASPASE INHIBITOR; CYTOCHROME C; DNA FRAGMENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MEDULLOBLASTOMA; MELANOMA; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BRAIN NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOBLASTOMA; HUMANS; MEDULLOBLASTOMA; TRITERPENES; TUMOR CELLS, CULTURED;

EID: 0032969291     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990730)82:3<435::AID-IJC18>3.0.CO;2-1     Document Type: Article

References (29)

1. DEBATIN, K.-M., Anticancer drugs, programmed cell death and the immune system: defining new roles in an old play. J. nat. Cancer Inst., 89, 750-751 (1997).
2. DEEN, D.F., CHIARODO, A., GRIMM, E.A., FIKE, J.R., ISRAEL, M.A., KUN, L.E., LEVIN, V.A., MARTON, L.J., PACKER, R.J. and PEGG, A.E., Brain tumor working group report on the 9th international conference on brain tumor research and therapy. J. Neurooncol., 16, 243-272(1993).
3. FISHER. D.E., Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542 (1994).
4. FRIEDMAN, H.S., OAKES, W.J., BIGNER, S.H., WIKSTRAND, C.J. and BIGNER, D.D., Medulloblastoma: tumor biological and clinical perspectives. J. Neurooncol., 11, 1-15 (1991).
5. FULDA, S., FRIESEN, C., LOS, M., SCAFFIDI, C., MIER, W., BENEDICT, M., NUÑEZ, G., KRAMMER, P.H., PETER, M.E. and DEBATIN, K.-M., Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res., 57, 4956-4964 (1997a).
6. FULDA, S., LOS, M., FRIESEN, C. and DEBATIN, K.-M., Chemosensitivity of solid tumor cells is associated with activation of the CD95 system. Int. J. Cancer, 76, 105-114 (1998a).
7. FULDA, S., SCAFFIDI, C., PIETSCH, T., KRAMMER, P.H., PETER, M.E. and DEBATIN. K.-M., Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain-tumor cells. Cell Death Differ., 5, 884-893 (1998b).
8. FULDA, S., SCAFFIDI, C., SUSIN, S.A., KRAMMER, P.H., KROEMER, G., PETER, M.E. and DEBATIN, K.-M., Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid. J. biol. Chem., 273, 33942-33948 (1998c).
9. FULDA, S., SIEVERTS, H., FRIESEN, C., HERR, I. and DEBATIN, K.-M., The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res., 57, 3823-3829 (1997b).
10. FULDA, S., SUSIN, S.A., KROEMER, G. and DEBATIN, K.-M., Molecular ordering of drug-induced apoptosis in neuroblastoma cells. Cancer Res., 58, 4453-4460 (1998d).
11. KROEMER, G., The protooncogene Bcl-2 and its role in regulating apoptosis. Nature Med., 3, 614-620 (1997).
12. KROEMER, G., ZAMZAMI, N. and SUSIN, S.A., Mitochondrial control of apoptosis. Immunol. Today, 18, 44-51 (1997).
13. LEIST, M., FAVA, E., MONTECUCCO, C. and NICOTERA, P., Peroxynitrite and nitric oxide donors induced neuronal apoptosis by eliciting autocrine excitotoxicity. Europ. J. Neurosci., 9, 1488-1498 (1997).
14. LI, P., NIJHAWAN, D., BUDIHARDIO, I., SRINIVASULA, S., AHMAD, M., ALNEMRI, A.S. and WANG, X., Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-489 (1997).
15. MILES, D.H., KOKPOL, U., ZALKOW, L.H., STEINDELL, S.J. and NABORS, J.B., Tumor inhibitors I: preliminary investigation of antitumor activity of Sarracenia flava. J. pharm. Sci., 63, 613-615 (1974).
16. MUZIO, M. and 12 OTHERS, FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85, 817-827 (1996).
17. NAGATA, S., Apoptosis by death factor. Cell, 88, 355-365 (1997).
18. NICOLETTI, I.. MIGLIORATI, G., PACLIACCI, M.C., GRIGNANI, F. and RICCARDI, C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. immunol. Methods, 139, 271-279 (1991).
19. PETER, M.E., KISCHKEL, F.C., HELLBRANDT, S., CHINNAIYAN, A.M., KRAMMER, P.H. and DIXIT, V.M., CD95 (APO-1/Fas)-associating signaling proteins. Cell Death Differ., 3, 161-170 (1996).
20. PISHA, E. and 14 OTHERS, Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nature Med., 1, 1046-1051 (1995).
21. RIEBER, M. and STRASBERG-RIEBER, M., Induction of p53 without increase in p21WAF1 in betulinic acid-mediated cell death is preferential for human metastatic melanoma. DNA Cell. Biol., 17, 399-406 (1998).
22. SANDBERG, F., DUTSCHEWSKA, H., CHRISTOV, V. and SPASSOV, S., Spondiathus preussii var. glaber Engler. Pharmaceutic screening of triterpenes. Acta pharm. suec., 24, 253-256 (1987).
23. SCAFFIDI, C., FULDA. S., LI, F., FRIESEN, C., SRINIVASAN, A., TOMASELLI, K.J., DEBATIN, K.-M., KRAMMER, P.H. and PETER. M.E., Two CD95 signaling pathways. EMBO J., 17, 1675-1687 (1998).
24. SCAFFIDI, C., MEDEMA, J.P., KRAMMER, P.H. and PETER, M.E., FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J. biol. Chem., 272, 26953-26958 (1997).
25. SCHMIDT, M.L., KUZMANOFF, K.L., LING-INDECK, L. and PEZZUTO, J.M., Betulinic acid induces apoptosis in human neuroblastoma cell lines. Europ. J. Cancer, 33, 2007-2010 (1997).
26. SHETH, K., JOLAD, S., WIEDHOPF, R. and COLE, J.R., Tumor-inhibitory agents from Hyptis emoryi (Labiatae). J. pharm. Sci., 61, 18-19 (1912).
27. STEVENS, M.C., CAMERON, A.H., MUIR, K.R., PARKES, S.E., REID, H. and WHITWELL, H., Descriptive epidemiology of primary central nervous system tumors in children: a population-based study. Clin. Oncol. R. Coll. Radiol., 3, 323-329 (1991).
28. THOMPSON, C.B., Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462 (1995).
29. TRAUTH, B.C., KLAS, C., PETER, A.M.J., MATZ, S., MÖLLER, P., FALK, W., DEBATIN, K.-M. and KRAMMER, P.H., Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science, 245, 301-305 (1989).